Nobivac NXT canine/feline-3 rabies
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Nobivac® NXT 3-Rabies is a non-adjuvanted, freeze-dried injectable rabies vaccine, utilizing RNA particle technology. The vaccine stimulates expression of the desired antigen to induce a
protective immune response against rabies.
INDICATIONS: This product has been shown to be effective for vaccination of healthy dogs and cats 12 weeks of age or older against rabies. Duration of Immunity is at least 3 years after a repeat dose. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.<
Product Details
| Therapeutic Use | Vaccine |
| Approved Species | Cat, Dog |
| Form | Powder for suspension |
| Route of Administration | Intramuscular, Subcutaneous |
| Pack Size | 1 x 25-vial pack |
Safety & Storage
Storage: Refrigerated
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Merck Sant\u00E9 Animale (Intervet Canada Corp.) |
|---|---|
| Pack Size | 1 x 25-vial pack |
Storage & Shipping
| Storage Conditions | Refrigerated |
|---|
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
